Kazutomo ToyofukuSeptember 19, 2025

FDA 483 - Kazutomo Toyofuku - September 19, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kazutomo Toyofuku

Record Details

An FDA inspection of Kazutomo Toyofuku, M.D. in Shinjuku-ku, Tokyo, Japan, a clinical investigator, revealed a significant deficiency in conducting a foreign clinical study. The study was not performed in accordance with Good Clinical Practices, specifically regarding inadequate justification for revisions made to source records weeks after initial entry. This indicates issues with data integrity and adherence to established research protocols.

Company: Kazutomo Toyofuku
Inspection Date: September 19, 2025
Product Type: Drugs
Office: Office of Inspections and Investigations
Person: Lakecha N. Lewis (Business Analyst/Provider Enrollment Specialist)

Open in Dashboard

ID · 4db92e0f-cebc-4a9d-b149-f31cd669c908